Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (4)
  • 2024 (1)
  • 2023 (3)
  • 2022 (6)
  • 2021 (7)
  • 2020 (1)

Subject

  • Drug Trafficking (32)
  • Take Back Day (26)
  • Prescription Drugs (23)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Synthetic drugs (14)
  • Fake Pills (13)
  • Congressional Affairs (12)
  • Major Law Enforcement Operation (11)
  • Press Conferences (11)
  • Arrests/Convictions - Major (10)
  • Diversion Division (10)
  • Fentanyl Awareness (10)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Money Laundering (6)
  • OCDETF/Task Force (5)
  • Overdose (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Fentanyl Free America (3)
  • Gangs (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Outreach/Drug Prevention (23)

Drug Name

  • Fentanyl (7)
  • Methamphetamine (3)
  • Opioids (2)
  • Oxycodone (1)
  • Synthetic Opioids (1)

Field Division

  • Omaha (33)
  • Washington, DC (27)
  • El Paso (12)
  • Rocky Mountain (11)
  • Seattle (11)
  • St. Louis (10)
  • New Orleans (9)
  • Miami (7)
  • Phoenix (7)
  • Detroit (5)
  • San Diego (5)
  • Los Angeles (4)
  • Dallas (3)
  • New England (3)
  • New York (3)
  • Philadelphia (3)
  • Atlanta (2)
  • Chicago (2)
  • Houston (2)
  • New Jersey (2)
  • San Francisco (2)
  • Louisville (1)
  • Sede (23)
Clear All Results
23 Results - Showing 11 to 20
PRESS RELEASE

DEA Teams up with more than 4,300 Partners to Remove Unneeded Prescription Medications from Communities

WASHINGTON – On Oct. 29, 2022, communities across the country demonstrated their continued support for DEA’s bi-annual National Prescription Drug Take Back Day by safely disposing of more than 647,000 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s National Prescription...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

WASHINGTON – On Sunday, August 21, the Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations –...
PRESS RELEASE

DEA Holds Inaugural Family Summit on the Overdose Epidemic

WASHINGTON – On June 14 and 15, DEA Administrator Anne Milgram hosted the first-ever DEA Family Summit on the Overdose Epidemic for families from across the country who have experienced the profound loss of a child due to a drug overdose or poisoning. Deputy Attorney General Lisa O. Monaco delivered...
PRESS RELEASE

DEA Recognizes First Ever National Fentanyl Awareness Day

WASHINGTON – In an effort to save lives, DEA is proud to join “Song for Charlie” and many of our valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat that...
PRESS RELEASE

DEA’s Commitment to Expanding Access to Medication-Assisted Treatment

WASHINGTON – Today, Administrator Anne Milgram announced the Drug Enforcement Administration’s continued commitment to expanding access to medication-assisted treatment to help those suffering from substance use disorder. “In this moment, when the United States is suffering tens of thousands of opioid-related overdose deaths every year, the DEA’s top priority is...
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

WASHINGTON, DC – The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
PRESS RELEASE

DEA Finalizes Measures to Expand Medication-Assisted Treatment

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...
PRESS RELEASE

DEA Wins International Award for Publication Aimed at Preventing Drug Misuse Among College Students

WASHINGTON – The U.S. Drug Enforcement Administration has been recognized by the National Association of Government Communicators for its publication designed for colleges and universities. Prevention with Purpose: A Strategic Planning Guide to Preventing Drug Misuse Among College Students, was awarded the Blue Pencil & Gold Screen Award of Excellence...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Current page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster